RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FIZAZI K
Collezione AOU San Luigi di Orbassano

Items : 8

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). in European urology / Eur Urol. 2025 Feb;87(2):157-216. doi: 10.1016/j.eururo.2024.09.017. Epub 2024 Oct 11.

2025
AOU San Luigi di Orbassano

Gillessen S; Turco F; Davis ID; Efstathiou JA; Fizazi K; James ND; Shore N; Small E; Smith M; Sweeney CJ; Tombal B; Zilli T; Agarwal N; Antonarakis ES; Aparicio A; Armstrong AJ; Bastos DA; Attard G; Axcrona K; Ayadi M; Beltran H; Bjartell A; Blanchard P; Bourlon MT; Briganti A; Bulbul M; Buttigliero C; Caffo O; Castellano D; et alii...

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De

2024
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Turco F; Gillessen S; Di Maio M; Vogl UM; Tucci M; Buttigliero C; Di Maio M; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Gillessen S; Turco F; Tucci M; Vogl UM;

Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study. in European urology oncology / Eur Urol Oncol. 2024 Oct;7(5):1132-1140. doi: 10.1016/j.euo.2024.03.013. Epub 2024 Apr 24.

2024
AOU San Luigi di Orbassano

Flippot R; Telli T; Velev M; Fléchon A; De Vries-Brilland M; Turpin L; Bergman A; Turco F; Mahammedi H; Fendler WP; Giraudet AL; Josset Q; Montravers F; Vogel W; Gillessen S; Berardi Vilei S; Herrmann K; Kryza D; Paone G; Hadaschik B; Merlin C; Dufour PA; Bernard-Tessier A; Naoun N; Patrikidou A; Garcia C; Foulon S; Pagès A; Fizazi K; et alii...

Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1. in European urology / Eur Urol. 2023 Apr;83(4):352-360. doi: 10.1016/j.eururo.2022.05.030. Epub 2022 Jun 22.

2023
AOU San Luigi di Orbassano

Healy C; Bhattacharyya H; Gurney H; Maruzzo M; Higano CS; Renard V; Machiels JP; Stirling A; Scagliotti G; Mehra N; Dorff T; Barthélémy P; de Bono J; Saad F; Arondekar B; Niyazov A; Fizazi K;

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. in The oncologist / Oncologist. 2022 Oct 1;27(10):e783-e795. doi: 10.1093/oncolo/oyac172.

2022
AOU San Luigi di Orbassano

Mehra N; Fizazi K; de Bono JS; Barthélémy P; Dorff T; Stirling A; Machiels JP; Bimbatti D; Kilari D; Dumez H; Buttigliero C; van Oort IM; Castro E; Chen HC; Di Santo N; DeAnnuntis L; Healy CG; Scagliotti GV;

Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11]. in European urology / Eur Urol. 2022 Jul;82(1):e18-e19. doi: 10.1016/j.eururo.2022.04.004. Epub 2022 Apr 16.

2022
AOU San Luigi di Orbassano

Turco F; Armstrong A; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Bulbul M; Caffo O; Chi KN; Clarke C; Clarke N; Davis ID; de Bono J; Duran I; Eeles R; Efstathiou E; Efstathiou J; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; George D; Gleave M; Halabi S; Heinrich D; et alii...

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. in European urology / Eur Urol. 2022 Jul;82(1):6-11. doi: 10.1016/j.eururo.2022.02.010. Epub 2022 Feb 17.

2022
AOU San Luigi di Orbassano

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10.

2021
AOU San Luigi di Orbassano

de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K;